0001209191-22-032953.txt : 20220531
0001209191-22-032953.hdr.sgml : 20220531
20220531182048
ACCESSION NUMBER: 0001209191-22-032953
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220526
FILED AS OF DATE: 20220531
DATE AS OF CHANGE: 20220531
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Horton Kenneth L
CENTRAL INDEX KEY: 0001552047
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37717
FILM NUMBER: 22985100
MAIL ADDRESS:
STREET 1: VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Senseonics Holdings, Inc.
CENTRAL INDEX KEY: 0001616543
STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL [3823]
IRS NUMBER: 471210911
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 20451 SENECA MEADOWS PARKWAY
CITY: GERMANTOWN
STATE: MD
ZIP: 20876
BUSINESS PHONE: (301) 515-7260
MAIL ADDRESS:
STREET 1: 20451 SENECA MEADOWS PARKWAY
CITY: GERMANTOWN
STATE: MD
ZIP: 20876
FORMER COMPANY:
FORMER CONFORMED NAME: ASN Technologies, Inc.
DATE OF NAME CHANGE: 20140813
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-05-26
0
0001616543
Senseonics Holdings, Inc.
SENS
0001552047
Horton Kenneth L
C/O SENSEONICS HOLDINGS, INC.
20451 SENECA MEADOWS PARKWAY
GERMANTOWN
MD
20876
0
1
0
0
GC & Corp. Development Advisor
Common Stock
2022-05-26
4
A
0
45000
0.00
A
1216995
D
Common Stock
2022-05-26
4
A
0
431035
0.00
A
1648030
D
Represents a Restricted Stock Unit ("RSU") grant. The RSUs vest on May 15, 2023, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.
Each RSU represents a contingent right to receive one share of the Issuer's common stock.
Represents an RSU grant. The RSUs vest in eight equal installments with the first installment vesting on June 15, 2022 and the remaining
seven installments vesting in six month increments commencing on November 15, 2022, subject to the Reporting Person's continuous service with the
Issuer as of the applicable vesting date.
/s/ Darren K. DeStefano, Attorney-in-Fact
2022-05-31